DSIP (Delta Sleep-Inducing Peptide)
Delta Sleep-Inducing Peptide (DSIP) is a natural neuropeptide that regulates slow-wave sleep and reduces stress hormones. It is key for research into sleep disorders and circadian rhythm.
$48.99
-
Official retailer
-
Quality guaranteed
-
Within 2 Days Delivery
-
99% Purified
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide known for its regulatory role in sleep patterns, stress hormone levels, and central nervous system function. DSIP has garnered interest for its ability to modulate slow-wave sleep, reduce cortisol levels, and support homeostatic recovery during stress. It is used in research focused on sleep disorders, neuroendocrine balance, and circadian rhythm optimization.
– Form: Lyophilized peptide
– Purity: >99%
– Origin: Manufactured and tested in the USA
– Documentation: Certificate of Analysis (COA) included
DSIP is believed to act on specific regions of the hypothalamus and pituitary axis, influencing neuroendocrine signaling. It promotes delta wave (slow-wave) sleep, helps regulate melatonin and corticotropin secretion, and exhibits adaptogenic-like properties. Its precise mechanism remains under investigation, making it an important subject in sleep research.
– Sleep onset and maintenance studies
– Stress-response models involving cortisol
– Neuroendocrine regulation
– Recovery optimization in fatigue and overtraining
– Circadian rhythm modulation
– Supports deep/restorative sleep cycles
– Reduces plasma cortisol levels in stress models
– Enhances hypothalamic-pituitary balance
– Potential adaptogen in neural recovery protocols
Each vial is:
– Produced in a GMP-compliant U.S. facility
– Accompanied by a Certificate of Analysis (COA)
– Verified via HPLC and mass spectrometry
– Securely shipped with quality-control documentation
– Contents: 5mg DSIP lyophilized peptide
– Appearance: White to off-white powder
– Solubility: Reconstitute with sterile bacteriostatic water
– Storage: Store at -20°C; refrigerate after reconstitution and use within 30 days
*For research use only. Not for human or veterinary consumption.*
– Intended for laboratory research only
– Not approved for human consumption or clinical use
– Buyer assumes all responsibility for legal research use
DSIP targets deep (delta wave) sleep cycles and also plays a role in hormonal regulation, making it ideal for studies on restorative sleep and recovery.
Yes, DSIP has been shown to reduce elevated cortisol levels in stress models, which may help support healthy circadian patterns.
Its effects may vary depending on the sleep architecture being studied. It is best suited for research focused on slow-wave sleep and stress-related dysregulation.
Each batch is tested for >99% purity and confirmed with HPLC and mass spectrometry. A Certificate of Analysis (COA) is included.
Semax should be stored in lyophilized form at -20°C in a dry, dark environment. After reconstitution, it should be refrigerated between 2–8°C and used promptly according to lab protocol.
Shop Peptides Direct provides Semax at ≥98% purity, verified by HPLC and Mass Spectrometry. A batch-specific Certificate of Analysis (COA) is included with every order.
Yes. While Semax is stable in our standard temperature-resistant packaging, cold-chain shipping is available for labs with more stringent transport requirements.
Yes. Semax is sometimes studied alongside nootropic peptides like Selank or neurotrophic factors in research examining synergistic cognitive and neuroprotective effects. All use must follow appropriate research protocols.
Visit our Lab Test Results page, select ‘Semax’ from the dropdown, and enter your email. Your batch-specific COA will be sent directly to you for verification and documentation.
Our Semax is ≥98% pure, made in the USA, and supported by full lab documentation. We offer same-day shipping, responsive customer service, and a Price Match Guarantee—find the same quality for less, and we’ll match it.
DSIP (5 mg & 10 mg Vial) Dosage Protocol
Quickstart Highlights
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its effects on sleep architecture and stress modulation[1][2]. Research indicates DSIP may promote delta-wave (slow-wave) sleep, modulate cortisol and ACTH levels, and exhibit stress-protective properties[3][4]. This educational protocol presents a once-daily subcutaneous evening approach using practical dilutions for clear insulin-syringe measurements.
- 5 mg Vial Reconstitution: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
- 10 mg Vial Reconstitution: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
- Typical daily range: 100–300 mcg once daily in the evening (gradual titration).
- Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg; at 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Dosing & Reconstitution Guide
Educational guide for reconstitution and nightly dosing
Standard / Gradual Approach (Both Vials)
| Week | Daily Dose (mcg) | 5 mg Vial (Units) | 10 mg Vial (Units) |
|---|---|---|---|
| Week 1 | 100 mcg | 6 units (0.06 mL) | 3 units (0.03 mL) |
| Week 2 | 150 mcg | 9 units (0.09 mL) | 5 units (0.05 mL) |
| Week 3 | 200 mcg | 12 units (0.12 mL) | 6 units (0.06 mL) |
| Weeks 4–8 | 250–300 mcg | 15–18 units (0.15–0.18 mL) | 8–9 units (0.08–0.09 mL) |
Frequency: Inject once daily subcutaneously in the evening, approximately 30–60 minutes before bedtime[5]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
Advanced / Extended Approach
| Week | Daily Dose (mcg) | 5 mg Vial (Units) | 10 mg Vial (Units) |
|---|---|---|---|
| Week 5 | 350–400 mcg | 21–24 units (0.21–0.24 mL) | 11–12 units (0.11–0.12 mL) |
| Weeks 6–8+ | 400–500 mcg | 24–30 units (0.24–0.30 mL) | 12–15 units (0.12–0.15 mL) |
Note: Advanced dosing (beyond 300 mcg) is based on anecdotal experience; formal human studies have primarily used doses up to ~300 mcg daily[6]. Use the minimum effective dose and increase only if needed.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Supplies Needed
Plan based on an 8–12 week nightly protocol with gradual titration.
- Peptide Vials (DSIP):
- 5 mg Vials: 8 weeks at ~200 mcg/day avg ≈ 2–3 vials
- 5 mg Vials: 12 weeks at ~300 mcg/day avg ≈ 5–6 vials
- 10 mg Vials: 8 weeks ≈ 1 vial (10 mg supports ~33–100 doses at 100–300 mcg)
- 10 mg Vials: 12 weeks ≈ 2 vials
- Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- 5 mg: 3 vials: 9 mL → 1 × 10 mL bottle
- 10 mg: 2 vials: 6 mL → 1 × 10 mL bottle
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
Protocol Overview
Concise summary of the once-daily evening regimen.
- Goal: Support healthy sleep architecture, enhanced delta-wave sleep, and stress modulation over time[3][4].
- Schedule: Daily subcutaneous injections in the evening for 4–12 weeks.
- Dose Range: 100–300 mcg daily with gradual titration; advanced up to 500 mcg.
- Reconstitution: 3.0 mL per vial for accurate unit measurements (1.67 mg/mL for 5 mg, 3.33 mg/mL for 10 mg).
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested nightly titration approach.
- Start: 100 mcg nightly; increase by ~50 mcg every 1–2 weeks as tolerated.
- Target: 250–300 mcg nightly by Weeks 4–8.
- Frequency: Once per day (subcutaneous), 30–60 minutes before bedtime.
- Cycle Length: 4–12 weeks; consider a break after the cycle.
- Timing: Evening dosing to align with natural sleep onset; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[7].
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~4 weeks and avoid freeze–thaw[8].
- Allow vials to reach room temperature before opening to reduce condensation uptake.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[9].
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose and site rotation to maintain consistency.
- Some research suggests DSIP effects may persist for multiple nights after dosing[2]; adjust frequency as needed.
- Avoid other sedatives during DSIP use to clearly evaluate its effects on sleep.
How This Works
DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain[1]. Mechanistic studies suggest DSIP may influence sleep by modulating GABAergic transmission and interacting with opioid receptor systems[10]. Research indicates it can increase delta-wave (slow-wave) sleep duration without significantly altering REM sleep architecture[3]. Beyond sleep, DSIP has demonstrated stress-protective and adaptogenic properties in various models, potentially through modulation of the hypothalamic-pituitary-adrenal axis[4][11]. Unlike conventional sedatives, DSIP tends to normalize sleep architecture without next-day grogginess[12].
Potential Benefits & Side Effects
Observations from preclinical and clinical literature.
- May promote deeper, more restorative slow-wave sleep and improve subjective sleep quality[3][5].
- Research suggests potential stress-protective and anxiolytic-like effects[4][11].
- Some studies indicate DSIP does not induce pharmacological tolerance with continued use[2].
- Remarkably safe profile: animal studies found no lethal dose even at extremely high doses; human studies report only mild, transient side effects[1][13].
- Generally well tolerated; occasional mild injection-site reactions may occur with subcutaneous administration.
Lifestyle Factors
Complementary strategies for best outcomes.
- Maintain consistent sleep-wake schedules to reinforce circadian rhythms.
- Limit blue light exposure and stimulants (caffeine, nicotine) in the hours before bed.
- Create a cool, dark, quiet sleep environment to support natural melatonin production.
- Incorporate regular physical activity, ideally earlier in the day.
- Manage stress through relaxation techniques (meditation, deep breathing).
Injection Technique
General subcutaneous guidance from clinical best-practice resources[14].
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[14][15].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[14].
- Rotate sites systematically (abdomen at least 2 inches from navel, thighs, upper arms) to avoid lipohypertrophy[15].
- Using a 30- or 50-unit insulin syringe improves accuracy when measuring small volumes.
Recommended Source
We recommend Shop Peptides Direct for high-purity DSIP (5 mg & 10 mg).
Why Shop Peptides Direct?
- High-purity, third-party-tested lots with batch COAs.
- Consistent, ISO-aligned handling and documentation.
- Reliable fulfillment to maintain cold-chain integrity.
Important Note
This content is for educational purposes only and is not medical advice. DSIP is for research use only. Not for human consumption. Always consult with qualified professionals before starting any peptide research protocol.
References
-
Schoenenberger GA, Monnier M (1977) — Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci USA
-
European Journal of Anaesthesiology (2001) — Delta sleep-inducing peptide: editorial review of mechanisms and clinical context
-
Schneider-Helmert D, Schoenenberger GA (1983) — Effects of DSIP in man: multifunctional psychophysiological properties. Neuropsychobiology
-
Sudakov KV et al. (2004) — Delta-sleep-inducing peptide sequelae: stress protective effect. Ann N Y Acad Sci
-
Schneider-Helmert D (1981) — Acute and delayed effects of DSIP on human sleep behavior. Int J Clin Pharmacol Ther Toxicol
-
Iyer KS et al. (1988) — Sleep-inducing effect of low doses of DSIP in rats. Indian J Exp Biol
-
Manning MC et al. (2010) — Stability of protein pharmaceuticals: an update. Pharm Res
-
Wang W (2000) — Lyophilization and development of solid protein pharmaceuticals. Int J Pharm
-
MedlinePlus — Subcutaneous Injection Instructions — Site rotation, technique, and patient education
-
Yehuda S, Carasso RL (1988) — DSIP: brain mechanisms and function. Int J Neurosci
-
Khvatova EM et al. (2003) — Delta sleep-inducing peptide: effect on oxidative stress in brain during different models. Biull Eksp Biol Med
-
European Neurology (PubMed) — Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia
-
European Neurology (PubMed) — Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic pain episodes
-
CDC — Subcutaneous Injection Administration — Technique, angle, aseptic procedure, no aspiration required
-
NCBI Bookshelf — Medication Administration: Subcutaneous Injections — Best practices for injection (asepsis, preparation, and administration)
RELATED PRODUCTS
Glutathione
LL-37
Semax
View Certificate
Humanin
SS-31 (Elamipretide)
View Certificate
Reviews
There are no reviews yet.